https://doi.org/10.1073/pnas.1101657108
J
James Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
178
Papers
5.8K
Citations
33
h-index
64
i10-index
James Kim is an academic researcher from Mayo Clinic Hospital. The author has contributed to research in topics: Hedgehog Signaling Pathway Studies & Epigenetics and DNA Methylation & RNA and protein synthesis mechanisms. The author has an h-index of 33, co-authored 152 publications.
ORCID: 0000-0002-2992-9222Papers by this author
worksHedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
2011 · Proceedings of the National Academy of Sciences · 339 citations
Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
2013 · Cancer Cell · 329 citations
https://doi.org/10.1016/j.ccr.2012.11.017
Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
2014 · Journal of Clinical Oncology · 278 citations
https://doi.org/10.1200/jco.2013.49.9525
CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation
2019 · Nature Communications · 220 citations
https://doi.org/10.1038/s41467-019-12028-5
The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
2020 · Nature Metabolism · 137 citations
https://doi.org/10.1038/s42255-020-00316-0
p63 and SOX2 Dictate Glucose Reliance and Metabolic Vulnerabilities in Squamous Cell Carcinomas
2019 · Cell Reports · 91 citations
https://doi.org/10.1016/j.celrep.2019.07.027
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat